Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 2.00 | 89.50 | 0.0223 | -0.7991 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 2.00 | 89.50 | 0.0223 | -0.7991 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 2.00 | 89.50 | 0.0223 | -0.7991 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 2.00 | 89.50 | 0.0223 | -0.7991 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 5.00 | 89.50 | 0.0559 | -0.6504 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 3.00 | 89.50 | 0.0335 | -0.7433 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 2.00 | 89.50 | 0.0223 | -0.7991 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 56.00 | 89.50 | 0.6257 | 0.5063 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 86.00 | 89.50 | 0.9609 | 0.9523 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 83.00 | 89.50 | 0.9274 | 0.9109 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 156.25 | 28.44 | 75.00 | 89.50 | 0.8380 | 0.7973 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 156.25 | 28.44 | 125.00 | 89.50 | 1.3966 | 1.4476 |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 156.25 | 28.44 | 168.00 | 89.50 | 1.8771 | 1.9266 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 156.25 | 28.44 | 131.00 | 89.50 | 1.4637 | 1.5180 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 156.25 | 28.44 | 208.00 | 89.50 | 2.3240 | 2.3300 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 156.25 | 28.44 | 91.00 | 89.50 | 1.0168 | 1.0202 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 156.25 | 28.44 | 123.00 | 89.50 | 1.3743 | 1.4239 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 172.00 | 89.50 | 1.9218 | 1.9686 | |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 156.25 | 28.44 | 60.00 | 89.50 | 0.6704 | 0.5705 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 156.25 | 28.44 | 177.00 | 89.50 | 1.9777 | 2.0204 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 156.25 | 28.44 | 135.00 | 89.50 | 1.5084 | 1.5642 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 156.25 | 28.44 | 142.00 | 89.50 | 1.5866 | 1.6438 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 156.25 | 28.44 | 117.00 | 89.50 | 1.3073 | 1.3517 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 156.25 | 28.44 | 93.00 | 89.50 | 1.0391 | 1.0469 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 156.25 | 28.44 | 110.00 | 89.50 | 1.2291 | 1.2656 |